
Microparticle MIS416 shows promise in treating progressive MS in clinical trial
MIS416 is a microparticle that has been developed in New Zealand by Innate Immunotherapeutics and may offer a

MIS416 is a microparticle that has been developed in New Zealand by Innate Immunotherapeutics and may offer a

There has been growing interest amongst MS researchers in statins, drugs that are routinely used to lower cholesterol,

Mrs Claire Luck was a person with MS, who in 2010, made the decision to pledge her brain

A new 2014 MS Research Australia project grant holds particular promise for tackling the progressive forms of MS.

University of NSW Associate Professor David Brown, from the St Vincent’s Centre for Applied Medical Research in Sydney,

 MS Research Australia has recently completed an audit of all research outcomes from our funding since 2004. Whilst

This event provides a unique opportunity for Australian neuroscientists and researchers to come together, present their latest findings

Researchers from the Florey Institute of Neuroscience and Mental Health in Melbourne have revealed exciting new possibilities for

MS Research Australia is pleased to announce $1.537 million in new funding to begin in 2014. This includes